Fix MedicareBy Cutting Drug Prices
July 21, 2004 -- CuttingUS drug prices to the levels of other countries would allow seniors to get enhanced drug coverage and close a major gap in Medicare coverage, according to an analysis posted online todayin Health Affairs by Gerard Andersonand his colleagues at Johns Hopkins and Penn State. The abstract of their article is as follows:
In 2003 citizens of Canada, the United Kingdom, and France paid an average of 34-59 percent of what Americans paid for a similar market basket of pharmaceuticals. If the Medicare program were to pay comparable prices for pharmaceuticals, it would be possible to eliminate the "doughnut hole" in its prescription drug benefit and keep Medicare drug spending within the overall limits established by Congress. This provides Congress with a clear choice -- reduce the level of cost sharing and improve beneficiaries' access to pharmaceuticals, or allow the pharmaceutical industry to use the higher prices to fund research and development and to engage in other activities.
At the moment, there is no choice. The Medicarebill that the US Congress passed and President Bush signed into law in December bars the government from directly negotiating priceswith drug manufacturers.
MarketWatch: Doughnut holes and price controls. Gerard F. Anderson, Dennis G. Shea, Peter S. Hussey, Salomeh Keyhani, Laurie Zephyrin. Health Affairs, posted online July 21, 2004.
Barbara K. Hecht,
Last Editorial Review: 7/21/2004
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions